June 28, 2017 – In the spring of 2017, the HRS Subcommittee on Reimbursement and Regulatory Affairs released a statement recommending that private payers provide coverage for subcutaneous implantable cardiac defibrillator (S-ICD) therapy, consistent with FDA labeling.
Topic
- Coding
- Reimbursement
Resource Type
- Guidelines & Protocols
Related Resources

Educational Materials
Heart Rhythm Society Health Policy Initiatives
The Heart Rhythm Society's mission is to improve the care of patients by promoting research, education and optimal health care policies and standards.
March 18, 2025

Clinical Best Practices
Heart Rhythm 2024 Quality Improvement and Health Policy OnDemand (FREE on HRS365)
Access the Heart Rhythm 2024 Quality Improvement program.
March 15, 2025

Guidelines & Protocols
HRS and the American Medical Association (AMA)
Since 2010, HRS has defended the interests of electrophysiologists’ on payment changes policies through its partnership with the American Medical Association. That partnership relies on…
February 26, 2025